Phloretin in the same model improved anxiety-like behavior, locomotor activity, and neural survival by upregulating the antioxidant Nrf2, a downstream target of PERK (Shirgadwar et al., 2023). The gene discussed is EIF2AK3; the disease is Anxiety.